JeffreyM.FarmaMDFACS

Colon & Rectal Surgery, Melanoma, Surgical Oncology (Other than Breast), Minimally Invasive Surgery

Chair of Surgery Fox Chase Cancer Center Professor of Surgical Oncology, Surgical Director Melanoma and Skin Cancer Program

Join to view full profile

Dr. Farma is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Farma's full profile

Already have an account?

Office
333 Cottman Avenue
Philadelphia, PA 19111
Phone+1 215-728-2419

Fax+1 215-728-2773

Summary

I'm so proud to be the Chair of Surgery at Fox Chase Cancer Center. I trained in general surgery at Temple University Hospital. During my fellowship at the National Cancer Institute.

My clinical surgical oncology fellowship at the Moffitt Cancer Center in Tampa, Florida has provided me with an extensive understanding of the multidisciplinary approach to treating patients with cancer. One of the greatest benefits of a cancer center like Fox Chase is the cohesive group of expert physicians from all specialties that are constantly interacting and providing the highest level of care using the most innovative strategies to treat all aspects of cancer. I have developed a particularly strong interest in the surgical and multimodal treatment of patients with Melanoma, Sarcoma and Colorectal cancers, using traditional surgery, regional therapies, and minimally invasive techniques. I have the operative expertise to perform many of these complex procedures using laparoscopic, robotic, and TAMIS (transaanal minimally invasive surgery) techniques and have had advanced training in using newest techniques. I am an expert in the treatment of colorectal cancer including; sphincter sparing and nerve sparing resections, and treating patients with hereditary colorectal cancer syndromes.

For melanoma and sarcoma that has regional spread in the extremities I offer a minimally invasive technique call Isolated Limb Infusion, and perform minimally invasive inguinal lymph node dissections.

Most importantly, I hold my patients as my number one priority and value the patient experience and ways we can utilize surgical oncology to improve quality of life.

Farma Is Chair of Surgery at Fox Chase

American College of Surgeons Member News Update- September 2024

Immunotherapy Drugs Extend Survival for Patients With Advanced Melanomas

MONDAY, Sept 16, 2024 (HealthDay News) -- A decade of patient follow-up finds a combo of two immunotherapy drugs can greatly extend survival for people with adv

Fox Chase Cancer Center Appoints Dr. Jeffrey M. Farma Chair of Surgery

PHILADELPHIA (June 10, 2024)- Fox Chase Cancer Center has appointed Jeffrey M. Farma, MD, FACS, to Chair of Surgery following a succession of leadership roles a

After Sarah Ferguson's diagnosis, Philadelphia doctor says breast cancer and mel

A Fox Chase Cancer Center doctor says there is a genetic connection between some types of breast cancer and melanoma.

Sarah Ferguson Diagnosed With Skin Cancer

MONDAY, Jan. 22, 2024 (HealthDay New) -- Sarah Ferguson, the Duchess of York, announced Monday that she has been diagnosed with melanoma, an aggressive form of

At-home stool tests for colorectal cancer screening are rising in popularity, bu

At-home stool tests can be an easier way to screen for colorectal cancer than a dreaded colonoscopy. As the rates of the cancer continue to rise in younger peop

Drs. Claire Raab and Jeffrey Farma Featured in Profiles in Modern Luxury Medicin

Claire Raab, MD, President and CEO of Temple Faculty Physicians, and Jeffrey M. Farma, MD, FACS, Co-Director of the Melanoma and Skin Cancer Program and Chief o

What's Happening this Week: Phillies-Marlins series, August 9-11

On Tuesday, August 9, the Phillies kick off a three-game series against the Miami Marlins at Citizens Bank Park. Here's a look at the promotions and fun surroun

The Future of Melanoma: What to Anticipate in 2022- Aim Melanoma

With Anthony J. Olszanski, MD, RPh and Jeffrey M. Farma, MD, FACS, co-directors of Fox Chase Cancer Center's Melanoma and Skin Cancer Program.

New Data Shed Light on Gastrostomy Tube Recipients

Adjuvant and Neoadjuvant Therapy in Melanoma

Understanding Treatment Options in Melanoma

Philadelphia Celebration Ceremony 2020 - Meet Dr. Jeffrey Farma of Fox Chase Can

We hope you all enjoyed the Miles for Melanoma Philadelphia Celebration Ceremony on the MRF Facebook live on Saturday, August 29th, 2020! A special thank you

#13: Dr. Jeffrey Farma - Surgical Oncology, Fox Chase Cancer Center - Narratives

Today's guest is surgical oncologist Dr. Jeffrey Farma. He is truly "Temple Made". A former Temple University Medical Student, he went to Temple for his general

Nodal Classification System Improves Assessment of Cutaneous Melanoma Mortality

NEW YORK (Reuters Health) - A modified prognostic nodal classification system improved mortality risk stratification for cutaneous melanoma when contrasted with

Jeffrey M. Farma, MD, FACS Updates Healio.com on colorectal cancer

Updates on colorectal cancer screening and treatment options

Federal panel says colon cancer screening should start at 45, not 50, as the dis

In response to an alarming, long-term increase in colorectal cancer among younger people, an influential federal panel on Tuesday lowered the recommended age to

Thiazides associated with increased risk for skin cancer in older adults

Adults aged over 65 years who took thiazides for hypertension had an increased risk for keratinocyte carcinoma and melanoma, according to results of a populatio

Clinical trial aims to improve treatment for early-stage colorectal cancer

PHILADELPHIA (WPVI) -- There is a clinical trial going on that hopes to change the way patients with early-stage colorectal cancer are treated. Fox Chase Cancer

Together Facing Melanoma 2020

Learn more about melanoma treatment at Fox Chase: https://bit.ly/3jA1a2S.A recording of our virtual Together Facing Melanoma event where an expert panel of F...

Together Facing Colorectal Cancer 2020

A recording of our virtual Together Facing Colorectal Cancer event where an expert panel of Fox Chase clinicians discussed treatment options, genetic testing...

An Extraordinary Oncology Nurse: I Wish We Could Clone Her

Jeffrey M. Farma, M.D., and Kim Gaier, RN - PHOTOS BY KRISTA PATTON Our team has worked together now for the past four years at Fox Chase Cancer Center (FCCC).

'Truly Amazing': Huge Change in Melanoma Prognosis

Back in 2005, when Philip Friedlander, MD, PhD, completed his fellowship, the first clinical trials of checkpoint inhibitor clinical trials were just beginning,

Fox Chase Cancer Center supports colon cancer run/walk

Enon Tabernacle Baptist Church is hosting its annual Know Your Numbers Men's Health Initiative on March 14 from 8 a.m. to 8 p.m. at 2800 W. Cheltenham Ave. Male

COVID-19 Vaccines: Here is What Cancer Patients and Survivors Need to Know Now

We know that the COVID-19 vaccinations approved for use in the United States are both safe and highly effective. Both the Pfizer BioNTech and Moderna COVID-19

Isolated Limb Infusion for Melanoma and Sarcoma at Fox Chase Cancer Center

Isolated Limb Infusion (ILI) is a regional technique which involves temporarily isolating the blood supply to an extremity to concentrate chemotherapy treatment

Together Facing Colorectal Cancer

FOX CHASE CANCER CENTER CHAT RECAP: Colorectal Cancer Awareness and prevention

Colorectal cancer is the third most common cancer diagnosed in both men and women in the United States, excluding skin cancers. But, it's also one of the most p

MRF Miles For Melanoma Philadelphia Virtual 2020

Fox Chase Cancer Center - Division of General Surgery Updates

Enjoy the videos and music you love, upload original content, and share it all with friends, family, and the world on YouTube.

Cancer Care Turned Upside Down - The Academic Surgeon

As a surgical oncologist, I have developed principles that helped me build a successful practice; provide excellent care to my patients; work and lead multidisc

irAEs Linked to Ipilimumab Should Not Preclude Subsequent Anti-PD-1 Therapy

Patients with advanced melanoma can safely undergo anti-programmed death-1 (PD-1) therapy even after having experienced severe immune-related toxicities

Surgical Changes and Recommendations during COVID 19: NCCN Melanoma Guidelines Explained
From the Clinic to the Living Room: Conversations with Melissa Wilson, PA-C, MPAS SPECIAL GUEST: Jeffrey M. Farma, MD, FACS Co-Director, Melanoma and Skin Cancer Program Chief, Division of General Surgery Professor, Department of Surgical Oncology Program Director, Complex General Surgical Oncology Fellowship Fox Chase Cancer Center Jeffrey Farma, MD, has built a career as a leading clinical expert in complex surgical oncology, as well as a clinical researcher and educator. He has served as the Society of Surgical Oncology (SSO) fellowship program director since 2013 and has a national and growing international reputation, having authored or co-authored more than 150 peer reviewed publications, chapters, and abstracts. He specializes in treating colorectal cancer, melanoma, sarcoma, and minimally invasive and robotic surgery. Dr. Farma serves in several leadership positions at Fox Chase and within the oncology field. He is co-director of the Fox Chase Melanoma and Skin Cancer program, a member of the National Comprehensive Cancer Network (NCCN) panel on non-melanoma skin cancer, and an award-winning advocate and fundraiser for area sarcoma, colorectal cancer, and skin cancer organizations. Dr. Farma has been an integral part of Fox Chase for more than two decades, first as a medical student, then as a resident. He returned to Fox Chase as an attending surgeon after completing his residency in general surgery at Temple University Hospital and surgical oncology fellowships at Moffitt Cancer Center in Tampa and the National Cancer Institute in Bethesda, Maryland.
Posted by AIM at Melanoma on Wednesday, May 27, 2020

AIM at Melanoma: Surgical Changes and Recommendations during COVID-19:

NCCN Melanoma Guidelines Update

We Are Here For You - Fox Chase Physicians

Our physicians would like to send a message to our patients.

A Day (or Two) in the Life of Surgical Oncologist Jeffrey Farma - Fox Chase Canc

Precision, compassion, patience, determination, and dedication - these are key traits of any good surgeon. Luckily for his patients at Fox Chase Cancer Center,

Fox Chase Goes Live on Facebook to Talk About Skin Cancer | Fox Chase Cancer Cen

During a Facebook Live Q&A on skin cancer on May 10, Jeffrey Farma, MD, a surgical oncologist with a treatment focus that includes skin cancer, and behavioral s

Fox Chase Cancer Center to Raise Funds at Miles for Melanoma Philadelphia

PHILADELPHIA (October 2, 2017) - Fox Chase Cancer Center is the local presenting sponsor of the 2017 Miles for Melanoma Philadelphia. The run/walk starts at 8 a

Carla Rake and Dr. Jeffrey Farma

Carla Rake, a melanoma survivor treated at Fox Chase Cancer Center, speaks about her cancer journey with her doctor. Jeffrey Farma, MD, FACS. The video was play

Dr. Jeffrey Farma on Mentorship

Jeffrey Farma, MD, FACS, outlines how to be a good mentor, including sharing your successes, pitfalls, and what you've learned.

Jeffrey M. Farma, MD, FACS

Surgical Director, Melanoma and Skin Cancer Program Dr. Farma works with a multidisciplinary team to treat patients with cancer. More at Foxchase.org

Education & Training

University of South Florida MorsaniFellowship, Complex General Surgical Oncology, 2007 - 2009
Temple University HospitalResidency, Surgery, 2000 - 2007
National Cancer Institute2003 - 2005
Lewis Katz School of Medicine at Temple UniversityClass of 2000
Tufts UniversityB.A., 1992 - 1996

Certifications & Licensure

PA State Medical License 2001 - 2024
FL State Medical License 2008 - 2010
American Board of Surgery Surgery

Awards, Honors, & Recognition

Colombian Surgical Association International Visiting Professorship Award Association for Academic Surgery, 2020
European Society of Surgical Oncology Observership Society of Surgical Oncology, 2019
Humanitarian Award Melanoma Research Foundation, 2016
2014 Travelling Fellowship to Germany American College of Surgeons, 2014
Regional Top Doctor Castle Connolly, 2014
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Best Clinical Poster Presentation H. Lee Moffitt Cancer Center 2008 Fellow’ Education Research Symposium, 2008
Surgery Resident Research Symposium Award Temple University, 2007
H. Taylor Caswell Award Department of Surgery Teaching Award for outstanding Chief Surgical Resident, 2007
ASCO Foundation Merit Award 2005
ASCO Merit Award ASCO
Fellow (FACS) American College of Surgeons
Join now to see all

Clinical Trials

Multicenter Selective Lymphadenectomy Trial II (MSLT-II) Start of enrollment: 2004 Sep 30
Completed
Not Applicable
Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery Start of enrollment: 2011 May 25
Active, not recruiting
Phase 3
Minimally Invasive Groin Dissection for Melanoma Start of enrollment: 2012 Jun 01
Completed
Not Applicable
PROSPECT: Chemotherapy Alone or Chemotherapy Plus Radiation Therapy in Treating Patients With Locally Advanced Rectal Cancer Undergoing Surgery Start of enrollment: 2012 Jun 12
Active, not recruiting
Phase 2, Phase 3
Tavo and Pembrolizumab in Patients With Stage III/IV Melanoma Progressing on Either Pembrolizumab or Nivolumab Treatment Start of enrollment: 2017 Oct 03
Active, not recruiting
Phase 2
Navtemadlin and Radiation Therapy in Treating Patients With Soft Tissue Sarcoma Start of enrollment: 2018 Jun 20
Active, not recruiting
Phase 1
Organ Preservation in Early Rectal Cancer Patients Start of enrollment: 2018 May 11
Suspended
Phase 2
Efficacy of Daromun Neoadjuvant Intratumoral Treatment in Clinical Stage IIIB/C Melanoma Patients Start of enrollment: 2018 Sep 20
Recruiting
Phase 3
Testing Pembrolizumab Versus Observation in Patients With Merkel Cell Carcinoma After Surgery, STAMP Trial Start of enrollment: 2018 Nov 15
Suspended
Phase 3
Registry of Sarcoma Patients Treated With Permanently Implantable LDR CivaSheet® Start of enrollment: 2020 Apr 30
Recruiting
Phase 4
Genomic Risk in Retroperitoneal Sarcoma Start of enrollment: 2022 Mar 07
Recruiting
Join now to see all

Publications & Presentations

PubMed

37 citations
Patient-Reported Outcomes During and After Treatment for Locally Advanced Rectal Cancer in the PROSPECT Trial (Alliance N1048).
Ethan Basch, Amylou C Dueck, Sandra A Mitchell, Harvey Mamon, Martin Weiser
Journal of Clinical Oncology. 2023-07-20
74 citations
Preoperative Treatment of Locally Advanced Rectal Cancer.
Deborah Schrag, Qian Shi, Martin R Weiser, Marc J Gollub, Leonard B Saltz
The New England Journal of Medicine. 2023-07-27
19 citations
Survival following intensive preoperative combined modality therapy with paclitaxel, cisplatin, 5-fluorouracil, and radiation in resectable esophageal carcinoma: a pha...
Melvyn Goldberg, Jeffrey M. Farma, Craig Lampert, Patrick Colarusso, Lawrence R. Coia
The Journal of Thoracic and Cardiovascular Surgery. 2003-10-01

Journal Articles

Basal Cell Skin Cancer, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology
Farma JM, JNCCN, 11/21/2023
Partial stomach-partitioning gastrojejunostomy as an alternative for palliation in patients with malignant gastric or duodenal outlet obstruction
Arrangoiz R, Papavasiliou P, Siripuapu V, Li T, Watson JC, Hoffman JP, Farma JM, American Journal of Surgery, 5/1/2013
Association of race and socioeconomic status and outcomes with patients with rectal cancer
Nitzkorski, James, Willis, A, Farma JM, Zhu F, Nick D, Sigurdson, E, Ann Surg Oncol, 1/1/2013
Donor transmission of melanoma following renal transplant
Chen KT, Olszanski A, Farma JM, Case Reports in Transplantation, 11/1/2012
A collision of diseases: chronic lymphocytic leukemia discovered during lymph node biopsy for melanoma
Farma JM, Zager JS, Barnica-elvir V, Puleo CA, Marzban SS, Rollison DE, Messina JL, Sondak VK, Ann Surg Oncol, 11/1/2012
Utility of PET/CT in the staging and treatment of patients with Merkel Cell Carcinoma and Melanoma
Papavasiliou P, Arrangoiz R, Farma JM, Journal of Nuclear Medicine and Radiation Therapy, 10/1/2012
Predicting pathologic response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer using FDG-PET/CT
Shanmugan S, Arrangoiz, R, Nitzkorski JR, Yu, JQ, Li T, Konski A, Farma JM. Sigurdson ER, Ann Surg Oncol, 7/1/2012
Preoperative FDG-PET/CT (PET) is an important tool in the management of patients with thick (T4) melanoma
Arrangoiz R., Papavasiliou P, Stransky CA, Yu JQ, Li T, Sigurdson ER, Berger AC, Farma JM, Dermatology Research and Practice, 5/1/2012
Case Report and Literature Review: Metastatic Lobular Carcinoma of the Breast an Usual Presentation
Arrangoiz R, Papavasiliou P, Farma J, International Journal of Surgery Case Reports, 10/1/2011
Outcome and natural history of patients with stage IV colorectal cancer receiving chemotherapy without primary tumor resection
Nitzkorski JR, Farma JM, Watson JC, Zhu F, Siriurapu V, Matteoti RS, Sigurdson ER, Ann Surg Oncol, 8/1/2011
Expression of the anti-apoptotic protein surviving in colon cancer
Hernandez, JM, Farma JM, Coppola D, Hakam A, Fulp WJ, Chen DT, Siegel EM, Yeatman TJ, Shibata D, Clinical Colorectal Cancer, 4/1/2011
Dermatofibrosarcoma protuberans: How wide should we resect?
Farma JM, Ammori JB, Zager JS et al, Ann Surg Oncol, 3/1/2010
Minimally Invasive Surgery for Esophageal Cancer
Santillan AA, Farma JM, Meredith KL, Shah NR, Kelley ST, JNCCN, 10/1/2008
PET/CT Fusion Scan Enhances CT Staging in Patients with Pancreatic Neoplasms
Farma JM, Santillan AA, Melis M, Walters J, Belinc D, Chen D, Eikman, E, Malafa M, Ann Surg Oncol, 6/1/2008
Proper Margins of Excision in Dermatofibrosarcoma Protuberans: Wide or Narrow?
Zager JS, Bui MM, Farma JM, Messina JL, Sondak VK, Ann Surg Oncol, 5/1/2008
Direct Evidence for Rapid and Selective Induction of Tumor Neovascular Permeability by Tumor Necrosis Factor and a Novel Derivative, Colloidal Gold Bound Tumor Necrosi...
Farma JM, Puhlmann M, Cox D, Soriano, PA, Paciotti GF, Tamarkin L, Alexander HR, Int J Cancer, 6/1/2007
A Pneumonia That Will Not Go Away
Farma JM, Mohiuddin, J, Grewal H, Contemporary Surgery, 4/1/2007
Non-neoplastic Celiac Axis Occlusion in Patients Undergoing Pancreaticoduodenectomy
Farma JM, Hoffman JP, Am J Surg, 3/1/2007
Limited Survival in Patients with Carcinomatosis from Foregut Malignancies after Cytoreduction and Continuous Hyperthermic Peritoneal Perfusion
Farma JM, Pingpank JF, Libutti SK, Bartlett DL, Ohl S, Beresneva T, Alexander HR Jr, J Gastrointest Surg, 12/1/2005
Interleukin-1beta Induced Vascular Permeability is Dependent on Induction of Endothelial Tissue Factor (TF) Activity
Puhlmann M, Weinreich DM, Farma JM, Carroll NM, Turner EM, Alexander HR Jr, J Transl Med, 9/1/2005
Complete Response to Neoadjuvant Chemoradiotherapy in Esophageal Carcinoma is Associated with Significantly Improved Survival
Berger AC, Farma J, Scott WJ, Freedman G, Weiner L, Cheng JD, Wang H, Goldberg M, J Clin Oncol, 3/1/2005
Cardiac Tamponade
Farma J, Nguyen D, Postgrad Med J, 1/1/2005
Survival Following Intensive Preoperative Combined Modality Therapy with Paclitaxel, Cisplatin, 5-Fluorouracil and Radiation in Resectable Esophageal Carcinoma – A Pha...
Goldberg M, Farma J, Lampert C, Colarusso P, Coia L, Frucht H, Goosenberg E, Beard M, Weiner LM, J Thorac Cardiovasc Surg, 10/1/2003
Laparoscopic Repair of Diaphragmatic Hernia after Left Ventricular Assist Device
Farma J, Leeser D, Furukawa S, Dempsey DT, Journal of Laparoendoscopic & Advanced Surgical Techniques, 6/1/2003
Join now to see all

Books/Book Chapters

Surgical Oncology Clinics of North America
Chapter: Translational research in melanoma
Ray M, Farma JM, Hsu C2013
Diet and Nutrition in Palliative Care
Chapter: Palliative Gastrojejunostomy and the Impact on Nutrition in Cancer
Rao PB, Farma JMTaylor and Francis, CRC Press2011
Inherited Cancer Syndromes-Current Clinical Management
Chapter: Hereditary Breast Cancer Syndromes
Santillan AA, Farma JM, Hagmaeir R, Cox CE, Riker AI2010
Surgical Oncology, Multidisciplinary Approach to Difficult Problems
Chapter: Surgical management of metastatic liver disease
Farma JM, Tada H, Daly JMLippincott Williams & Wilkins, Philadelphia2009
Liver and Pancreatic Diseases Management (Advances in Experimental Medicine and Biology)
Chapter: Isolated Hepatic Perfusion: Treating Unresectable Liver Metastases
Farma JM, Pingpank JF, Alexander HRSpringer, New York, NY2006
Join now to see all

Abstracts/Posters

The presence of tumor infiltrating lymphocytes and their role as a prognostic indicator for melanoma
Reddy SS, Barnica-elvir V, Zhu F, Wu H, Olszanski AJ, Farma JM, HemOnc today melanoma and cutaneous malignancies- Poster Presentation, New York, NY, 3/1/2013
Decreased use of neoadjuvant chemoradiotherapy in patients with rectal cancer after treatment for prostate cancer
Wai CJ, Meyer JE, Zhu F, Sigurdson ER, Farma JM, Pennsylvania Society of Colon and Rectal Surgeons- Oral Presentation, Philadelphia, PA, 3/1/2013
Defying the Norm: Aggressive Early Stage Colon Cancers that Develop Distant Metastatic Recurrences
Wai CJ, Li T, Sigurdson ER, Farma JM, Pennsylvania Society of Colon and Rectal Surgeons- Poster Presentation, Philadelphia, PA, 3/1/2013
High mitotic rates in patients with cutaneous melanoma
Barnica-elvir V, Zhu Fang, Reddy S, Farma JM, Society of Surgical Oncology 66TH Annual Cancer Symposium- Poster Presentation, National Harbor, MD, 3/1/2013
Failure of surgical oncology education in general surgery residency
Wai CJ, Maher Z, Li T, Devajaran K, Crawford D, Thomay AA, Sigurdson ER, Farma JM, Society of Surgical Oncology 66TH Annual Cancer Symposium- Poster Presentation, National Harbor, MD, 3/1/2013
Treatment of colorectal cancers with minimally invasive surgical techniques at a dedicated cancer center
Reddy S, Sigurdson ER, Farma JM, ASCO GI Symposium-Poster Presentation, San Francisco, CA, 1/1/2013
Decreased use of chemoradiotherapy in patients with rectal cancer after treatment for prostate cancer
Wai CJ, Meyer JE, Fang Z, Sigurdson E, Farma JM, The American Society of Colon & Rectal Surgeons- Poster Presentation, San Antonio, TX, 6/1/2012
Low 18f-fluorodeoxyglucose uptake on positron emission tomography as a prognostic factor for stage I and II pancreatic cancer
Pimiento JM, Boutrid H, Weber JM, Razzaque S, Farma JM, Kim RD, Hodul PJ, Shridhar R, Hoffe SE, Almhanna K, Chuong MD, Chen DT, Springett GM, Eikman E, Klapman , Jong ..., Society of Surgical Oncology 65TH Annual Cancer Symposium- Poster Presentation, Orlando, FL, 3/1/2012
Challenges in treatment of angiosarcoma: A single institution experience
Singla S, Papavasiliou P, Powers B, Gaughan J, von Mehren M, Watson JC, Farma JM, Society of Surgical Oncology 65TH Annual Cancer Symposium- Oral Presentation, Orlando, FL, 3/1/2012
Optimal treatment approach for lymph node metastases in patients with Merkel cell carcinoma
Papavasiliou P, Chen KT, Arrangoiz, R, Murphy CT, Zhu F, Perlis C, Wu H, Turaka A, Farma JM, Society of Surgical Oncology 65TH Annual Cancer Symposium- Poster Presentation, Orlando, FL, 3/1/2012
Outcomes in Patients with Mucosal Melanomas
Keller D, Thomay AA, Gaughan J, Wu H, Farma JM, Society of Surgical Oncology 65TH Annual Cancer Symposium- Poster Presentation, Orlando, FL, 3/1/2012
Merkel Cell Carcinoma of Unknown Origin: A Better Prognosis?
Chen KT, Papavasiliou P, Zhu F, Perlis C, Wu H, Turaka A, Farma JM, Society of Surgical Oncology 65TH Annual Cancer Symposium- Poster Presentation, Orlando, FL, 3/1/2012
Imatinib-resistant GIST metastases; predicting outcomes of surgical resection
Chen KT, Farma JM, Von Mehren M, Watson JC, 7th annual Academic Surgical Congress- Oral presentation, Las Vegas, NV, 2/1/2012
Outcomes in Patients with Mucosal Melanomas
Keller D, Thomay AA, Gaughan J, Wu H, Farma JM, Resident Research Night: Philadelphia Academy of Surgery- Best Poster Presentation, Philadelphia, PA, 2/1/2012
Partial Stomach-Partitioning Gastrojejunostomy (PSPG) and the success of this procedure in terms of palliation
Arrangoiz R, Papavasiliou, P, Singla S, Siripurapu V, Watson JC, Hoffman JP, Farma JM, 7th annual Academic Surgical Congress- Oral presentation, Las Vegas, NV, 2/1/2012
Low 18f-fluorodeoxyglucose uptake on positron emission tomography as a prognostic factor for stage I and II pancreatic cancer
Pimiento JM, Boutrid H, Weber JM, Razzaque S, Farma JM, Kim RD, Hodul PJ, Shridhar R, Hoffe SE, Almhanna K, Chuong MD, Chen DT, Springett GM, Eikman E, Klapman , Jong ..., ASCO GI 2012- Poster Presentation, San Francisco, CA, 1/1/2012
Adjuvant radiotherapy in merkel cell carcinoma: a 20-year experience at a single institution
Murphy CT, Turaka A, Fang Z, Farma JM, Lango MN, Wu H, Engstrom P, Nicolaou N, Perlis C, ASTRO 2011- Poster Presentation, Miami, FL, 10/1/2011
Merkel cell carcinoma and sentinel lymph node evaluation: outcomes from a single institution
Turaka A, Murphy CT, Fang Z, Farma JM, Lango MN, Wu H, Engstrom P, Nicolaou N, Perlis C, ASTRO 2011- Poster Presentation, Miami, FL, 10/1/2011
Rectal Cancer Length by PET/CT Predicts Pathologic Complete Response
Arrangoiz R, Papavasiliou P, Nitzkorski J, Yu JQ, Sigurdson E, Farma JM, 97th American College of Surgeons Annual Clinical Congress -Poster Presentation, San Francisco, CA, 10/1/2011
Preoperative FDG-PET/CT (PET) is an important tool in the management of patients with thick (T4) melanoma
Arrangoiz R. Stransky CA, Papavasiliou P, Yu JQ, Li T, Kairys JC, Mastrangelo MJ, Sigurdson ER, Berger AC, Farma JM, Society of Surgical Oncology 64thAnnual Cancer Symposium- Poster Presentation, San Antonio, TX, 3/1/2011
Outcome and natural history of patients with stage IV colorectal cancer receiving chemotherapy without primary tumor resection
Nitzkorski JR, Farma JM, Matteoti RS, Siriurapu V, Zhu F, Sigurdson ER, Society of Surgical Oncology 64thAnnual Cancer Symposium- Oral Presentation, San Antonio, TX, 3/1/2011
Preoperative positron emission tomography/computed tomography changes management in patients with merkel cell carcinoma
Papavasiliou P, Arrangoiz R, Turaka A, Lango M, Yu JQ, Farma JM, Society of Surgical Oncology 64th Annual Cancer Symposium- Poster Presentation, San Antonio, TX, 3/1/2011
Association of race and socioeconomic status and outcomes with patients with rectal cancer
Nitzkorski JR, Willis AI, Farma JM, Cohen SJ, Zhu F, Nick DM, Sigurdson ER, Society of Surgical Oncology 64thAnnual Cancer Symposium- Poster Presentation, San Antonio, TX, 3/1/2011
Predicting pathologic response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer using FDG-PET/CT
Shanmugan S, Arrangoiz, R, Nitzkorski JR, Yu, JQ, Li T, Konski A, Farma JM, Sigurdson ER, Society of Surgical Oncology 64thAnnual Cancer Symposium- Oral Presentation, San Antonio, TX, 3/1/2011
Predicting pathologic response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer using FDG-PET/CT
Shanmugan S, Arrangoiz, R, Nitzkorski JR, Yu, JQ, Li T, Konski A, Farma JM, Sigurdson ER, ASCO GI Symposium- Poster Presentation, San Francisco, 1/1/2011
Join now to see all

Lectures

Prevention of Venous Thromboembolism in Fox Chase Cancer Center: Quality Initiative Project Update
Fox Chase Cancer Center, Philadelphia, PA - 6/1/2013
The Risks of Skin Cancer
Philadelphia, PA - 2/13/2013
Updates on the treatment of melanoma
Philadelphia, PA - 1/16/2013
Isolated Limb Infusion for in-transit cancer of the extremity
Fox Chase Cancer Center, Philadelphia, PA - 6/27/2012
Partnering for patient safety series- Anticoagulation
Fox Chase Cancer Center, Philadelphia, PA - 5/1/2012
Melanoma and Sarcoma Overview
Philadelphia, PA - 1/1/2012
Neoadjuvant Chemoradiation for Rectal Cancer
Pottstown Memorial Hospital, Pottstown, PA - 10/1/2011
Surgical Treatment of Melanoma
Fox Chase Cancer Center, Philadelphia, PA - 8/1/2011
Minimally Invasive Surgical Oncology
Philadelphia, PA - 6/1/2011
Colorectal Breakout Session
2/1/2011
Updates on the Current Treatment of Melanoma
South Jersey Healthcare, Vineland, NJ - 1/1/2010
Breakout session- Robotic Colorectal Surgery
Fox Chase Cancer Center, Philadelphia, PA - 11/1/2009
Multidisciplinary Fellow’s Conference Annual GI Symposium
H. Lee Moffitt Cancer Center, Tampa, FL - 4/1/2008
Targeted Cancer Therapies: Are We There Yet?
Temple University Hospital, Philadelphia, PA - 5/1/2007
In-Vivo Video Microscopy
Bethesda, MD - 5/1/2005
Join now to see all

Other

Case Study: 72-year-old Woman with Cystic Mass
Thomay AA, Then M, Farma JM, Chemotherapy Advisor website
http://www.chemotherapyadvisor.com/72-year-old-woman-with-cystic-mass/slideshow/1456/#0
7/29/2013
Clinical Decision Support- Dermatology
Papavasiliou, P, Zook M, Farma JM
1/1/2012

Press Mentions

Immunotherapy Drugs May Extend Survival for People with Advanced MelanomasSeptember 16th, 2024
Have fun in the sun, but protect your skin, expert saysJuly 14th, 2024
3 Tips for Protecting Your Skin While Having Fun in the SunJune 27th, 2024
Join now to see all

Committees

Chair, Fox Chase Cancer Center Medical Staff Executive Committee 2022 - Present
Chair, Association of Academic Surgery - Senior Council Member 2020 - Present
President, Metropolitan Philadelphia Chapter of the American College of Surgeons 2020 - Present
Chair, Society of Surgical Oncology-Program Director's Committee 2020 - Present
Surgical Specialty Trustee., PA MED Board of Trustees 2019 - Present
Panel Member, NCCN- Non-melanoma, Merkel Cell, Squamous Cell Carcinoma, Dermatofibrosarcoma Protuberans 2018 - Present
President of the Medical Executive Staff, Fox Chase Cancer Center 2020 - 2022